Impact of pituitary autoimmunity and genetic disorders on growth hormone deficiency in children and adults

5Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Growth hormone (GH), mostly through its peripheral mediator, the insulin-like growth factor 1(IGF1), in addition to carrying out its fundamental action to promote linear bone growth, plays an important role throughout life in the regulation of intermediate metabolism, trophism and function of various organs, especially the cardiovascular, muscular and skeletal systems. Therefore, if a prepubertal GH secretory deficiency (GHD) is responsible for short stature, then a deficiency in adulthood identifies a nosographic picture classified as adult GHD syndrome, which is characterized by heart, muscle, bone, metabolic and psychic abnormalities. A GHD may occur in patients with pituitary autoimmunity; moreover, GHD may also be one of the features of some genetic syndromes in association with other neurological, somatic and immune alterations. This review will discuss the impact of pituitary autoimmunity on GHD and the occurrence of GHD in the context of some genetic disorders. Moreover, we will discuss some genetic alterations that cause GH and IGF-1 insensitivity and the arguments in favor and against the influence of GH/IGF-1 on longevity and cancer in the light of the papers on these issues that so far appear in the literature.

Cite

CITATION STYLE

APA

Bellastella, G., Maiorino, M. I., Longo, M., Cirillo, P., Scappaticcio, L., Vietri, M. T., … De Bellis, A. (2020, February 2). Impact of pituitary autoimmunity and genetic disorders on growth hormone deficiency in children and adults. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms21041392

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free